APA

Vainshtein J., Abu-Isa E., Olson K. B., Ray M. E., Sandler H. M., Normolle D., Litzenberg D. W., Masi K., Pan C. & Hamstra D. A. (20121204). Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy. : Radiation oncology (London, England).

Chicago

Vainshtein Jeffrey, Abu-Isa Eyad, Olson Karin B, Ray Michael E, Sandler Howard M, Normolle Dan, Litzenberg Dale W, Masi Kathryn, Pan Charlie and Hamstra Daniel A. 20121204. Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy. : Radiation oncology (London, England).

Harvard

Vainshtein J., Abu-Isa E., Olson K. B., Ray M. E., Sandler H. M., Normolle D., Litzenberg D. W., Masi K., Pan C. and Hamstra D. A. (20121204). Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy. : Radiation oncology (London, England).

MLA

Vainshtein Jeffrey, Abu-Isa Eyad, Olson Karin B, Ray Michael E, Sandler Howard M, Normolle Dan, Litzenberg Dale W, Masi Kathryn, Pan Charlie and Hamstra Daniel A. Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy. : Radiation oncology (London, England). 20121204.